Short communication · 29 Nov 2025
Conference abstractPublished 17 Nov 2021
Liver disease and pharmacotherapy for alcoholism
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A common clinical question to addiction specialists concerns whether a medication to treat a patient???s alcoholism should be used and if so, when could such be commenced given the patient has liver disease. Alcohol consumption itself is a principal driver of alcoholic liver disease and as such, should prompt treatment intervention. While there is a reasonable evidence for medications that treat alcoholism, very little evidence exists to guide the decision to use such medication in the presence of clinically significant liver disease. This presentation reviews recent literature on pharmacotherapy for alcohol dependence relating particularly to patients having comorbid liver disease and alcoholism. It concludes with an outline for a Risk versus Benefit approach to pharmacotherapy decision making.
Keywords
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Hepatology and Pancreatic Science.
Short communication · 29 Nov 2025
Understanding Drug-Induced Liver and Pancreatic Toxicity
Opinion · 29 Nov 2025
Nanomedicine Enhances Hepatopancreatic Disorder Treatment
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHepatology and Pancreatic Science
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Mike McDonough”
